KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Elevance Health (ELV) Return on Sales (2016 - 2025)

Elevance Health (ELV) has disclosed Return on Sales for 16 consecutive years, with 0.01% as the latest value for Q4 2025.

  • Quarterly Return on Sales changed 0.0% to 0.01% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.03% through Dec 2025, down 1.0% year-over-year, with the annual reading at 0.03% for FY2025, 1.0% down from the prior year.
  • Return on Sales for Q4 2025 was 0.01% at Elevance Health, down from 0.02% in the prior quarter.
  • The five-year high for Return on Sales was 0.06% in Q2 2021, with the low at 0.01% in Q4 2024.
  • Average Return on Sales over 5 years is 0.04%, with a median of 0.04% recorded in 2022.
  • Peak annual rise in Return on Sales hit 4bps in 2021, while the deepest fall reached -3bps in 2021.
  • Over 5 years, Return on Sales stood at 0.04% in 2021, then skyrocketed by 38bps to 0.05% in 2022, then crashed by -64bps to 0.02% in 2023, then crashed by -52bps to 0.01% in 2024, then rose by 22bps to 0.01% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 0.01%, 0.02%, and 0.04% for Q4 2025, Q3 2025, and Q2 2025 respectively.